Masaru Matsuda plan to sell securities of ARCUTIS BIOTHERAPEUTICS, INC. under Form 144

Masaru Matsuda filed Form 144 to notify SEC of plan to sell 8256 units of ARCUTIS BIOTHERAPEUTICS, INC. securities around 2026-05-04, with aggregate market value of $192,415.53. The total outstanding units is 124033382.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months include: On 02/27/2026, sold 3325 units for $92933.75; On 03/02/2026, sold 8733 units for $220938.00;